Monoclonal antibody therapies against SARS-CoV-2 - The Lancet Infectious Diseases
The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates | Science Translational Medicine
新型コロナウイルス感染症に関する 国内外の研究開発動向について
An Analysis of Mesenchymal Stem Cell-Derived Extracellular Vesicles for Preclinical Use | ACS Nano
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
Frontiers | Developing Recombinant Antibodies by Phage Display Against Infectious Diseases and Toxins for Diagnostics and Therapy
SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion | Nature
Frontiers | The Mechanism of Lung and Intestinal Injury in Acute Pancreatitis: A Review
新型コロナウイルス感染症に関する 国内外の研究開発動向について
Guideline Therapeutics and COVID-19: living guideline
Easy & Reliable – Biomedica´s Cytokine ELISA Kits | Biomedica
Biophysical fitness landscape of the SARS-CoV-2 Delta variant receptor binding domain | bioRxiv
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
Biparatopic nanobodies protect mice from lethal challenge with SARS‐CoV‐2 variants of concern | EMBO reports
Advances in Nanomaterial-Based Platforms to Combat COVID-19: Diagnostics, Preventions, Therapeutics, and Vaccine Developments | ACS Applied Bio Materials
Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern - eBioMedicine
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
Rapid characterization of spike variants via mammalian cell surface display | bioRxiv
新型コロナウイルス感染症に関する 国内外の研究開発動向について
Human ACE2 Peptide-Attached Plasmonic-Magnetic Heterostructure for Magnetic Separation, Surface Enhanced Raman Spectroscopy Identification, and Inhibition of Different Variants of SARS-CoV-2 Infections | ACS Applied Bio Materials
SARS-CoV-2 neutralizing human recombinant antibodies selected from pre-pandemic healthy donors binding at RBD-ACE2 interface | Nature Communications
Rapid characterization of spike variants via mammalian cell surface display
